Bimanual Motor Skill Learning Through Robotics in Stroke Survivors and Healthy Individuals
Launched by UNIVERSITY HOSPITAL OF MONT-GODINNE · Jun 3, 2019
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how both healthy individuals and stroke survivors can learn and retain a specific motor skill using a special robot called REAplan. The goal is to see if practicing with this robot can help improve hand movements for those who have had a stroke. If you or a loved one has experienced a stroke more than six months ago, is between the ages of 18 and 90, and has a stroke-related injury visible on brain scans, you might be eligible to participate. Healthy individuals in the same age range can also join the study.
Participants in the trial can expect to engage in training sessions with the robot, which will help them practice and improve their hand movements. It's important to know that certain conditions may prevent someone from joining, like severe cognitive issues or complete paralysis of the affected arm. The study is currently recruiting participants, and it aims to better understand how this type of training can benefit both stroke survivors and healthy people by enhancing their motor skills.
Gender
ALL
Eligibility criteria
- STROKE PATIENTS :
- Inclusion Criteria:
- • having a chronic stroke (\>6 months)
- • aged 18-90 years
- • with demonstrate a stroke lesion on brain imaging.
- Exclusion Criteria:
- • difficulty in understanding or executing commands
- • drug/alcohol abuse
- • severe aphasia / cognitive deficits interfering with study
- • inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
- • multiple strokes / dementia / psychiatric condition
- • botulinum toxin injections (to be evaluated)
- HEALTHY INDIVIDUALS :
- Inclusion Criteria:
- • - 18-90 years
- Exclusion Criteria:
- • neurological conditions interfering with the study
- • drug/alcohol abuse
- • pyschiatric condition
About University Hospital Of Mont Godinne
The University Hospital of Mont-Godinne is a premier academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. With a strong emphasis on patient-centered care, the hospital actively participates in clinical trials that aim to enhance therapeutic options and improve health outcomes. Leveraging its affiliation with leading academic institutions, the hospital fosters a collaborative environment for researchers, healthcare professionals, and patients, ensuring that cutting-edge medical advancements translate effectively into practice. Committed to ethical standards and rigorous scientific protocols, the University Hospital of Mont-Godinne plays a vital role in the ongoing evolution of medical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yvoir, Namur, Belgium
Yvoir, Namur, Belgium
Patients applied
Trial Officials
Yves Y Vandermeeren, MD, PhD
Principal Investigator
Université catholique de Louvain, Institute of NeuroScience (IONS) NEUR / CHU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials